BioNexus Gene Lab (BGLC) Stock: Buy, Sell, or Hold?

BGLC - BioNexus Gene Lab Corp Common stock

SERVICES-MEDICAL LABORATORIES
$1.27
0.07 (5.83%) ▲
5d: -8.63%
30d: -13.61%
90d: -36.5%
WAIT
LOW Confidence
Analysis Updated: Oct 2, 2026 12:00 AM ET
Earnings: Nov 13, 2026

Get Alerted When BGLC Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
📊 MIXED SIGNALS: BGLC shows conflicting indicators. Wait for confirmation before entering.
See Forward Earnings Fair Value & Price Prediction →

In-depth Analysis How we analyze

Valuation Analysis: BGLC is currently trading at $1.27, which is considered oversold relative to its 30-day fair value range of $1.34 to $1.54.

Technical Outlook: Technically, BGLC is in a strong downtrend. Immediate support is located at $1.16, while resistance sits at $1.54. The stock is showing strong short-term momentum, up 5.8% recently.

Market Sentiment: BGLC scores 62/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position OVERSOLD
Historical Trading Range $1.34 - $1.54
Company Quality Score 48/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 100.0%

All Signals

  • BULLISH: Price oversold vs 30-day range
  • BULLISH: Strong technical setup (62/100)
  • BULLISH: High volume confirmation
  • BULLISH: Strong upward momentum (+5.8%)
  • WARNING: Composite score 48/100 in the bottom quintile — this cohort historically lags the market

Trading Range Analysis

30-Day Trading Range $1.34 - $1.54
Current vs Trading Range OVERSOLD

Support & Resistance Levels

Support Level $1.16
Resistance Level $1.54
Current Trend Strong Downtrend
Technical data as of Oct 2, 2026

Fundamental Context

Revenue Growth (YoY) -96.6%
Earnings Growth (YoY) -95.0%
Profit Margin -82.4%
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: October 02, 2026 9:47 PM ET
Data refreshes hourly during market hours. Next update: 10:47 PM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for BGLC.

Create Free Account

Already have an account? Log In

Top Rated Specialty Chemicals Stocks

Top-rated stocks in Specialty Chemicals by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
ECL
Ecolab Inc
STRONG BUY
27 analysts
$325 51 HOLD
LIN
Linde plc Ordinary Shares
BUY
28 analysts
$543 48 HOLD
SHW
Sherwin-Williams Co
BUY
28 analysts
$389 51 HOLD
APD
Air Products and Chemica…
BUY
24 analysts
$345 58 HOLD
ALB
Albemarle Corp
HOLD
28 analysts
$172 56 HOLD

More Analysis for BGLC

BGLC Technical Chart BGLC Price Prediction BGLC Earnings Date BGLC Investment Advisor BGLC Fair Price Analyzer BGLC Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals